Transgenomic PE Ratio 2010-2023 | PRPO
Current and historical p/e ratio for Transgenomic (PRPO) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Transgenomic PE ratio as of April 18, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Transgenomic PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-04-19 |
6.20 |
|
0.00 |
| 2023-12-31 |
6.50 |
$-4.56 |
0.00 |
| 2023-09-30 |
5.61 |
$-7.44 |
0.00 |
| 2023-06-30 |
7.80 |
$-9.20 |
0.00 |
| 2023-03-31 |
13.28 |
$-9.20 |
0.00 |
| 2022-12-31 |
11.03 |
$-10.60 |
0.00 |
| 2022-09-30 |
16.08 |
$-10.40 |
0.00 |
| 2022-06-30 |
21.20 |
$-9.20 |
0.00 |
| 2022-03-31 |
27.00 |
$-10.20 |
0.00 |
| 2021-12-31 |
31.60 |
$-7.80 |
0.00 |
| 2021-09-30 |
56.40 |
$-6.00 |
0.00 |
| 2021-06-30 |
72.60 |
$-8.60 |
0.00 |
| 2021-03-31 |
46.20 |
$-9.80 |
0.00 |
| 2020-12-31 |
41.40 |
$-23.80 |
0.00 |
| 2020-09-30 |
49.00 |
$-33.40 |
0.00 |
| 2020-06-30 |
28.40 |
$-35.40 |
0.00 |
| 2020-03-31 |
14.00 |
$-52.40 |
0.00 |
| 2019-12-31 |
41.00 |
$-46.40 |
0.00 |
| 2019-09-30 |
52.20 |
$-105.80 |
0.00 |
| 2019-06-30 |
67.60 |
$-150.58 |
0.00 |
| 2019-03-31 |
37.50 |
$-174.55 |
0.00 |
| 2018-12-31 |
46.20 |
$-305.88 |
0.00 |
| 2018-09-30 |
118.56 |
$-236.88 |
0.00 |
| 2018-06-30 |
110.34 |
$-593.70 |
0.00 |
| 2018-03-31 |
161.16 |
$-5,151.43 |
0.00 |
| 2017-12-31 |
360.00 |
$-5,640.81 |
0.00 |
| 2017-09-30 |
648.00 |
$-5,640.81 |
0.00 |
| 2017-06-30 |
2700.00 |
$-5,953.37 |
0.00 |
| 2017-03-31 |
6030.00 |
$-1,800.90 |
0.00 |
| 2016-12-31 |
2557.80 |
$-2,611.31 |
0.00 |
| 2016-09-30 |
2538.00 |
$-2,611.31 |
0.00 |
| 2016-06-30 |
4950.00 |
$-6,843.43 |
0.00 |
| 2016-03-31 |
5252.40 |
$-9,094.55 |
0.00 |
| 2015-12-31 |
9630.00 |
$-10,895.45 |
0.00 |
| 2015-09-30 |
8308.80 |
$-17,828.92 |
0.00 |
| 2015-06-30 |
15030.00 |
$-13,326.67 |
0.00 |
| 2015-03-31 |
12960.00 |
$-15,757.89 |
0.00 |
| 2014-12-31 |
18090.00 |
$-17,918.97 |
0.00 |
| 2014-09-30 |
33930.00 |
$-11,435.72 |
0.00 |
| 2014-06-30 |
33660.00 |
$-17,471.34 |
0.00 |
| 2014-03-31 |
41220.00 |
$-15,581.69 |
0.00 |
| 2013-12-31 |
49680.00 |
$-14,502.88 |
0.00 |
| 2013-09-30 |
41040.00 |
$-17,295.57 |
0.00 |
| 2013-06-30 |
43200.00 |
$-15,133.63 |
0.00 |
| 2013-03-31 |
43200.00 |
$-12,971.68 |
0.00 |
| 2012-12-31 |
65880.00 |
$-14,052.65 |
0.00 |
| 2012-09-30 |
102599.99 |
$-10,809.73 |
0.00 |
| 2012-06-30 |
97200.00 |
$-9,728.76 |
0.00 |
| 2012-03-31 |
129599.99 |
$-22,700.44 |
0.00 |
| 2011-12-31 |
139319.99 |
$-23,781.41 |
0.00 |
| 2011-09-30 |
139319.99 |
$-25,943.36 |
0.00 |
| 2011-06-30 |
188999.99 |
$-24,862.38 |
0.00 |
| 2011-03-31 |
95040.00 |
$-12,971.68 |
0.00 |
| 2010-12-31 |
71280.00 |
$-7,566.81 |
0.00 |
| 2010-09-30 |
43200.00 |
$-5,404.87 |
0.00 |
| 2010-06-30 |
52920.00 |
$-4,323.89 |
0.00 |
| 2010-03-31 |
92880.00 |
$-3,242.92 |
0.00 |
| 2009-12-31 |
74520.00 |
$-4,323.89 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.010B |
$0.015B |
|
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
|
